Immunopathogenic mechanisms of human immunodeficiency virus infection;MECANISMES IMMUNOPATHOLOGIQUES DE L'INFECTION PAR LE VIRUS DE L'IMMUNODEFICIENCE HUMAINE

Revue de Medecine Interne

Volumn 17, Issue 4, 1996, Pages 313-320

  Gluckman, J C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

escape; HIV; immune response; variability; viral load

Indexed keywords

HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNE SYSTEM; PATHOGENESIS; REVIEW; ANTIBODY PRODUCTION; CELLULAR IMMUNITY; DISEASE COURSE; IMMUNOLOGY; VIROLOGY;

ANTIBODY FORMATION; DISEASE PROGRESSION; HIV INFECTIONS; HUMANS; IMMUNITY, CELLULAR;

EID: 0029943791     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/0248-8663(96)81435-4     Document Type: Article

References (69)

1. Niu MT, Jerman JA, Reichelderfer P et al. Summary of the National Institute of Health workshop on primary human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 1993;9:913-24
2. Levy JA. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993;57:183-289
3. Pantaleo G, Fauci AS. New concepts in the immunopathogenesis of HIV infection. Annu Rev Immunol 1995;13:487-512
4. Clark SJ, Saag MS, Decker WD et al. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med 1991;324:954-60
5. Daar ES, Mougdil T, Meyer RD et al. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 1991;324:961-4
6. Chakrabarti L, Cumont MC, Montagnier L et al. Variable course of primary simian immunodeficiency virus infection in lymph nodes: relation to disease progression. J Virol 1994;68:6634-43
7. Reimann KA, Tenner-Racz K, Racz P et al. Immunopathogenic events in acute infection of Rhesus monkeys with simian immunodeficiency virus of macaques. J Virol 1994;68:2362-70
8. Yasutomi Y, Reimann KA, Lord CI et al. Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected Rhesus monkeys. J Virol 1993;67:1707-11
9. Ho DD. Time to hit HIV, early and hard. N Engl J Med 1995; 333:450-1
10. Clerici M, Levin JM, Kessler HA et al. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. JAMA 1994;271:42-6
11. Langlade-Demoyen P, Ngo Giang Huong N, Ferchal F et al. Human immunodeficiency virus (HIV) Nef-specific cytotoxic T lymphocytes in non-infected heterosexual contacts of HIV-infected patients. J Clin Invest 1994;93:1293-7
12. Paul WE. Can the immune response control HIV infection? Cell 1995;82:177-82
13. Zolla-Pazner S, Gorny MK. Passive immunization for the prevention and treatment of HIV infection. AIDS 1992;6:1235-47
14. Coffin JM. HIV population dynamics in vivo: implications for genetic variation, pathogenesis and therapy. Science 1995;267:483-9
15. Fenouillet E, Blanes N, Coutellier A et al. Monitoring of antibodies against human immunodeficiency virus type 1 p25 core protein as a prognostic marker. J Infect Dis 1992;16:611-6
16. Brand D, Truong C, Barin F. Domaines fonctionnels de l'enveloppe du VIH-1 et anticorps neutralisants. Med/Sci 1994;10:417-24
17. Belo M, Yagello M, Girard M et al. Antibody-dependent cellular cytotoxicity against HIV-1 in sera of immunized chimpanzees. AIDS 1991;5:169-76
18. Jouault T, Chapuis F, Olivier R et al. HIV infection of monocytic cells: role of antibody-mediated virus binding to Fc-gamma receptors. AIDS 1989;3:125-33
19. Wahren B, Morfeldt-Mansson L, Biberfeld G et al. Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. J Virol 1987;61:20l7-23
20. Clerici M. Cell-mediated immunity in HIV infection. AIDS 1993;7(Suppl 1):s135-40
21. Koup RA, Safrit JT, Cao Y et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immuno-deficiency virus type 1 syndrome. J Virol 1994;68:4650-5
22. Venet A, Walker BD. Cytotoxic T-cell epitopes in HIV/SIV infection. AIDS 1993;7(Suppl 1):s117-26
23. Bevan MJ, Braciale TJ. Why can't cytotoxic T cells handle HIV? Proc Natl Acad Sci USA 1995;92:5765-7
24. Venet A, Bourgault I, Aubertin AM et al. Cytotoxic T lymphocyte response against multiple simian immunodeficiency virus (SIV) proteins in SIV-infected macaques. J Immunol 1992;148:2899-908
25. Zinkernagel RM, Hengartner H. T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS. Immunol Today 1994;15:262-8
26. Knight SC, Macatonia SE, Bedford PA et al. Dendritic cells and HIV infection. In: Racz P, Dijkstra CD, Gluckman JC, eds. Accessory cells in HIV and other retroviral infections. Basel: Karger, 1991:145
27. Mosier D, Sieburg H. Macrophage-tropic HIV: critical for AIDS pathogenesis? Immunol Today 1994;145:332-9
28. Gluckman JC. L'immunothérapie active spécifique est-elle indiquée chez les sujets infectés par le virus de l'immunodéficience humaine (VIH)? In: Coulaud JP, Pocidalo JJ, Saimot AG, Vachon F, Vildé JL, éds. Perspectives thérapeutiques de l'infection par le VIH au stade précoce. Paris : Arnette, 1994:99
29. Graziosi C, Pantaleo G, Butini L et al. Kinetics of human immuno-deficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. Proc Natl Acad Sci Usa 1993;90:6405-9
30. Bagasra O, Hauptman SP, Lischner HW et al. Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction. N Engl J Med 1992; 326:1385-91
31. Piatak M, Saag MS, Yang LC et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-54
32. Patterson BK, Till M, Otto Petal. Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry. Science 1993;260:976-9
33. Nowak M, May RM. AIDS pathogenesis: mathematical models of HIV and SIV infections. AIDS 1993;7(Suppl 1):s3-18
34. Tenner-Racz K, Racz P, Bofil M et al. HTLA-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymph-adenopathy and AIDS. Am J Pathol 1986;123:9-15
35. Fox CH, Tenner-Racz K, Racz P et al. Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA. J Infect Dis 1991;164:1051-7
36. Pantaleo G, Graziosi C, Demarest JF et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-8
37. Embretson J, Zupancic M, Ribas JL et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of aids. Nature 1993;362:359-62
38. Janossy G. Bofill M, Racz P. Double immunofluorescence analysis of lymphoid tissues during HIV infection. In: Racz P, Haase AT, Gluckman JC, eds. Modern pathology of AIDS and other retroviral infections. Basel: Karger, 1990: 201
39. Ho DD, Neumann AU, Perelson AS et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6
40. Wei XP, Ghosh SK, Taylor ME et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-22
41. Spear GT. Interaction of non-antibody factors with HIV in plasma. AIDS 1993;7:1149-57
42. Koot M, Keet IPM, Vos AHV et al. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 1993;118:681-8
43. Connor RI, Mohri H, Cao Y et al. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J Virol 1993;67:1772-7
44. Wolinsky SM, Wike CM, Korber BTM et al. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 1992;255:1134-7
45. Zhu T, Mo H, Wang N et al. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 1993;261:1179-81
46. Schreiber M, Petersen H, Wachsmuth C et al. Antibodies of symptomatic human immunodeficiency virus type 1-infected individuals are directed to the V3 domain of noninfectious and not of infectious virions present in autologous serum. J Virol 1994;68:3908-16
47. Gluckman JC. Basic science challenging AIDS. In: Rossi GB, Beth-Giraldo E, Chieco-Bianchi L, Dianzani F, Giraldo G, Verani P, eds. Science Challenging AIDS. Basel: Karger, 1991:226
48. Nowak MA, May RM, Phillips RE et al. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 1995;375:606-11
49. Koup RA. Virus escape from CTL recognition. J Exp Med 1994;180:779-82
50. Wang SZS, Rushlow KE, Issel CJ et al. Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein. Virology 1994;199:247-51
51. Siebeling KHJ, Tijhaar E, Huisman RC et al. Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines. J Virol 1995;69:3704-11
52. Schlienger K, Montefiori DC, Mancini M et al. Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable to protect Rhesus monkeys from SIV experimental challenge. J Virol 1994;68:6778-88
53. Kliks SC, Shioda T, Haigwood NL et al. V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1993;90:11518-22
54. Gluckman JC. Immune responsiveness against the V3 loop of HIV-1 gp120 and animal models. In: Racz P, Letvin NL, Gluckman JC, eds. Animal models of HIV and other retroviral infections. Basel: Karger, 1993:10
55. Mascola JR, Mathieson BJ, Zack PM et al. Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials. AIDS Res Hum Retroviruses 1993;9:1175-84
56. Fultz PN, Gluckman JC, Muchmore E et al. Transient increases in numbers of infectious cells in an HIV-infected chimpanzee following immune stimulation. AIDS Res Hum Retroviruses 1992;8:313-7
57. O'brien WA, Grovit-Ferbas K, Namazi A et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 1995;86:1082-9
58. Reimann KA, Cate RL, Wu YM et al. In vivo administration of CD4-specific monoclonal antibody: effect on provirus load in Rhesus monkeys chronically infected with the simian immunodeficiency virus of macaques. AIDS Res Hum Retroviruses 1995;11:517-25
59. Koenig S, Conley AJ, Brehaw YA et al. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nature Med 1995;1:330-6
60. Bollinger RC, Quinn TC, Liu AY et al. Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: effects on viral replication. AIDS Res Hum Retroviruse, 1993;9:1067-77
61. Schwartz DH. Potential pitfalls on the road to an effective HIV vaccine. Immunol Today 1994;15:54-7
62. Battegay M, Kyburz D, Hengartner H et al. Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cells. Eur J Immunol 1993;23:3236-41
63. Baum H, Butler P, Davies H et al. Autoimmune disease and molecular mimicry: an hypothesis. Trends Biochem Sci 1993;18:140-4
64. Martin L, Idziorek T, Lehen A, Gluckman JC et al. Anti-CD4 auto-antibodies in HIV-infected persons: detection by two immunoenzymatic techniques. AIDS 1994;8:389-90
65. Manca F, Seravalli E, Valle MT et al. Non-covalent complexes of HIV gp120 with CD4 and/or mAbs enhance activation of gp 120-specific T clones and provide intermolecular help for anti-CD4 antibody production. Int Immunol 1993;5:1109-17
66. Neurath AR, Strick N, Li YY et al. Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins. AIDS Res Hum Retroviruses 1993;9:1195-1207
67. Levy JP, Venet A, Gomard E. Immunopathologie du syndrome d'immunodéficience acquise (sida). In: Bach JF, éd. Traité d'immunologie. Paris : Flammarion Médecine Science, 1993:1084
68. Cao YZ, Qin LM, Zhang LQ et al. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995;332:20l-8
69. Pantaleo G, Menzo S, Vaccarezza M et al. Studies in subjects with long term non-progressive human immunodeficiency virus infection. N Engl J Med 1995;332:209-16